126 related articles for article (PubMed ID: 38349269)
1. FGF12 restrains mitochondria-dependent ferroptosis in doxorubicin-induced cardiomyocytes through the activation of FGFR1/AMPK/NRF2 signaling.
Tian G; Li J; Wang W; Zhou L
Drug Dev Res; 2024 Feb; 85(1):e22149. PubMed ID: 38349269
[TBL] [Abstract][Full Text] [Related]
2. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation.
Zhang H; Pan J; Huang S; Chen X; Chang ACY; Wang C; Zhang J; Zhang H
Redox Biol; 2024 Apr; 70():103066. PubMed ID: 38359744
[TBL] [Abstract][Full Text] [Related]
4. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
5. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
[TBL] [Abstract][Full Text] [Related]
7. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms.
Zhuo C; Xin J; Huang W; Zhang D; Yan X; Li R; Li H; Lan J; Lin L; Li L; Wang X; Liu L; Wang Y; Li X; Mao Y; Chen H; Wu S; Yang X; Jiang W
Toxicology; 2023 Aug; 494():153597. PubMed ID: 37499777
[TBL] [Abstract][Full Text] [Related]
8. Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis.
Mei SL; Xia ZY; Qiu Z; Jia YF; Zhou JJ; Zhou B
Chin J Integr Med; 2022 Nov; 28(11):983-991. PubMed ID: 35997859
[TBL] [Abstract][Full Text] [Related]
9. Ling-Gui-Zhu-Gan decoction protects against doxorubicin-induced myocardial injury by downregulating ferroptosis.
Yang YL; Zhao CZ; Zhao CC; Wen ZY; Ma YY; Zhao XN; Wang L; Huang JL; Zhou P
J Pharm Pharmacol; 2024 Apr; 76(4):405-415. PubMed ID: 38241142
[TBL] [Abstract][Full Text] [Related]
10. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J
Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.
Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT
FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792
[TBL] [Abstract][Full Text] [Related]
14. Pachymic acid (PA) inhibits ferroptosis of cardiomyocytes via activation of the AMPK in mice with ischemia/reperfusion-induced myocardial injury.
Liu D; Ding J; Li Z; Lu Y
Cell Biol Int; 2024 Jan; 48(1):46-59. PubMed ID: 37750505
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide alleviates particulate matter-induced emphysema and airway inflammation by suppressing ferroptosis.
Wang Y; Liao S; Pan Z; Jiang S; Fan J; Yu S; Xue L; Yang J; Ma S; Liu T; Zhang J; Chen Y
Free Radic Biol Med; 2022 Jun; 186():1-16. PubMed ID: 35490984
[TBL] [Abstract][Full Text] [Related]
16. EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2.
Wang B; Jin Y; Liu J; Liu Q; Shen Y; Zuo S; Yu Y
Redox Biol; 2023 Sep; 65():102825. PubMed ID: 37531930
[TBL] [Abstract][Full Text] [Related]
17. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
18. [Electroacupuncture improves ischemic myocardial injury by activating Nrf2/HO-1 signaling pathway to inhibit ferroptosis in rats].
Jiang ZM; Zhang L; Liu L; Wang J; Cai RL; Hu L; Wu ZJ
Zhen Ci Yan Jiu; 2023 May; 48(5):461-7. PubMed ID: 37247859
[TBL] [Abstract][Full Text] [Related]
19. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
[TBL] [Abstract][Full Text] [Related]
20. Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway.
Han Y; Yuan H; Li F; Yuan Y; Zheng X; Zhang X; Sun J
BMC Complement Med Ther; 2023 Dec; 23(1):459. PubMed ID: 38102654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
